Fate of Transplanted Bone Marrow Derived Mesenchymal Stem Cells Following Spinal Cord Injury in Rats by Transplantation Routes

다국어 초록 (Multilingual Abstract)

This research was performed to investigate the differences of the transplanted cells’ survival and differentiation, and its efficacy according to the delivery routes following spinal cord injury. Allogenic mesenchymal stem cells (MSCs) were transplanted intravenously (IV group)or intralesionally (IL group) at post-injury 1 day in rats. Behavioral improvement,engraftment and differentiation of the transplanted cells and the expression of neurotrophic factors of the transplanted groups were analyzed and compared with those of the control group. At 6 weeks post-injury, the mean BBB motor scales in the control, IV and IL groups were 6.5 ± 1.8, 11.1 ± 2.1, and 8.5 ± 2.8, respectively. Regardless of the delivery route, the MSCs transplantation following spinal cord injuries presented better behavioral improvement. The differentiations of the engrafted cells were different according to the delivery routes. The engrafted cells predominantly differentiated into astrocytes in the IV group and on the other hand, engrafted cells of the IL group demonstrated relatively even neural and glial differentiation. The expressions of neuronal growth factor were significantly higher in the IL group (mean relative optical density,2.4 ± 0.15) than those in the control (2.16 ± 0.04) or IV group (1.7 ± 0.23).

Transplantation of MSCs in the early stage of spinal cord injury gives a significant clinical improvement. However, the fate of the transplanted MSCs and expression of neuronal growth factors are different along the transplantation route.

참고문헌 (Reference)

1 Kamada T, "Transplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord" 31 : 48-58, 2011

2 Song L, "Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow" 18 : 980-982, 2004

3 Wang DD, "The astrocyte odyssey" 86 : 342-367, 2008

4 Lindvall O, "Stem cells in human neurodegenerative disorders: time for clinical translation?" 120 : 29-40, 2010

5 Nandoe Tewarie RS, "Stem cell-based therapies for spinal cord injury" 32 : 105-114, 2009

6 황동훈, "Stem cell-based cell therapy for spinal cord injury" COGNIZANT COMMUNICATION CORP 16 : 355-364, 2007

7 Akiyama Y, "Remyelination of the spinal cord following intravenous delivery of bone marrow cells" 39 : 229-236, 2002

8 Ha KY, "Pregabalin as a neuroprotector after spinal cord injury in rats" 17 : 864-872, 2008

9 하기용, "Pregabalin as a Neuroprotector after Spinal Cord Injury in Rats: Biochemical Analysis and Effect on Glial Cells" 대한의학회 26 (26): 404-411, 2011

10 Ha KY, "Neuroprotective effect of moderate epidural hypothermia after spinal cord injury in rats" 33 : 2059-2065, 2008

11 Yoshihara T, "Neuroprotective effect of bone marrow-derived mononuclear cells promoting functional recovery from spinal cord injury" 24 : 1026-1036, 2007

12 Son BR, "Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases" 24 : 1254-1264, 2006

13 Haeyoung Suh-Kim, "Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model" 생화학분자생물학회 40 (40): 387-397, 2008

14 Caplan AI, "Mesenchymal stem cells as trophic mediators" 98 : 1076-1084, 2006

15 Takeuchi H, "Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner" 426 : 69-74, 2007

16 Osaka M, "Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome" 1343 : 226-235, 2010

17 Krampera M, "Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus" 40 : 382-390, 2007

18 Nomura T, "I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat" 136 : 161-169, 2005

19 Chu K, "Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia" 1016 : 145-153, 2004

20 정근화, "Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage" LIPPINCOTT WILLIAMS & WILKINS 34 : 2258-2263, 200309

21 Lee KH, "Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats" 67 : 13-22, 2007

22 Paul C, "Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods" 34 : 328-334, 2009

23 Zurita M, "Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation" 15 : 1105-1108, 2004

24 Parr AM, "Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery" 70 : 600-607, 2008

25 Azizi SA, "Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats: similarities to astrocyte grafts" 95 : 3908-3913, 1998

26 Imitola J, "Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway" 101 : 18117-18122, 2004

27 de Haro J, "Detection of 111In-oxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats" 377 : 7-11, 2005

28 Dong Hyun Kim, "Cotransplanted Bone Marrow Derived Mesenchymal Stem Cells (MSC) Enhanced Engraftment of Hematopoietic Stem Cells in a MSC-dose Dependent Manner in NOD/SCID Mice" 대한의학회 21 (21): 1000-1004, 2006

29 Wright KT, "Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications" 29 : 169-178, 2011

30 Yoon SH, "Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial" ALPHAMED PRESS 25 (25): 2066-2073, 200708

31 Vaquero J, "Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology" 24 : 107-116, 2009

32 Lu P, "BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury" 191 : 344-360, 2005

33 Neuhuber B, "Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations" 1035 : 73-85, 2005

34 Swanger SA, "Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord" 14 : 775-786, 2005

35 Woodbury D, "Adult rat and human bone marrow stromal cells differentiate into neurons" 61 : 364-370, 2000

36 Basso DM, "A sensitive and reliable locomotor rating scale for open field testing in rats" 12 : 1-21, 1995

37 Jung DI, "A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury" 285 : 67-77, 2009